356 related articles for article (PubMed ID: 32376492)
1. The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment.
Lopalco G; Rigante D; Cantarini L; Imazio M; Lopalco A; Emmi G; Venerito V; Fornaro M; Frediani B; Nivuori M; Brucato A; Iannone F
Trends Cardiovasc Med; 2021 Jul; 31(5):265-274. PubMed ID: 32376492
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 Blockers for the Treatment of Recurrent Pericarditis: Pathophysiology, Patient-Reported Outcomes, and Perspectives.
Thomas GK; Bonaventura A; Vecchié A; van Tassell B; Imazio M; Klein A; Luis SA; Abbate A
J Cardiovasc Pharmacol; 2024 Jun; 83(6):503-510. PubMed ID: 37163222
[TBL] [Abstract][Full Text] [Related]
3. Failure of anti Interleukin-1 β monoclonal antibody in the treatment of recurrent pericarditis in two children.
Signa S; D'Alessandro M; Consolini R; Miniaci A; Bustaffa M; Longo C; Tosca MA; Bizzi M; Caorsi R; Mendonça LO; Pession A; Ravelli A; Gattorno M
Pediatr Rheumatol Online J; 2020 Jun; 18(1):51. PubMed ID: 32546242
[TBL] [Abstract][Full Text] [Related]
4. Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim-Chester Disease.
Tomelleri A; Cavalli G; De Luca G; Campochiaro C; D'Aliberti T; Tresoldi M; Dagna L
Front Immunol; 2018; 9():1233. PubMed ID: 29910817
[TBL] [Abstract][Full Text] [Related]
5. Anakinra effectiveness in refractory polyserositis: An Italian multicenter study.
Lopalco G; Venerito V; Brucato A; Emmi G; Giacomelli R; Cauli A; Piga M; Parronchi P; Nivuori M; Malandrino D; Ruscitti P; Vitiello G; Fabiani C; Cantarini L; Iannone F
Joint Bone Spine; 2022 Mar; 89(2):105299. PubMed ID: 34656754
[TBL] [Abstract][Full Text] [Related]
6. Anakinra in Recurrent Pericarditis: Current Evidence on Clinical Use, Effectiveness, and Safety.
Correia ETO; Dos Santos Barbetta LM; de Almeida JPCL; Mesquita ET
J Cardiovasc Pharmacol; 2020 Jul; 76(1):42-49. PubMed ID: 32265370
[TBL] [Abstract][Full Text] [Related]
7. Acute Effects of Interleukin-1 Blockade Using Anakinra in Patients With Acute Pericarditis.
Wohlford GF; Buckley LF; Vecchié A; Kadariya D; Markley R; Trankle CR; Chiabrando JG; de Chazal HM; Van Tassell B; Abbate A
J Cardiovasc Pharmacol; 2020 Jul; 76(1):50-52. PubMed ID: 32398478
[TBL] [Abstract][Full Text] [Related]
8. Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonism.
Brucato A; Emmi G; Cantarini L; Di Lenarda A; Gattorno M; Lopalco G; Marcolongo R; Imazio M; Martini A; Prisco D
Intern Emerg Med; 2018 Jun; 13(4):475-489. PubMed ID: 29633070
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 blockade for the treatment of pericarditis.
Buckley LF; Viscusi MM; Van Tassell BW; Abbate A
Eur Heart J Cardiovasc Pharmacother; 2018 Jan; 4(1):46-53. PubMed ID: 28633474
[TBL] [Abstract][Full Text] [Related]
10. Inflammation and pericarditis: Are neutrophils actors behind the scenes?
Bonaventura A; Montecucco F
J Cell Physiol; 2019 May; 234(5):5390-5398. PubMed ID: 30417336
[TBL] [Abstract][Full Text] [Related]
11. Advances in pharmacotherapy for acute and recurrent pericarditis.
Vecchié A; Del Buono MG; Mauro AG; Cremer PC; Imazio M; Klein AL; Abbate A; Dentali F; Bonaventura A
Expert Opin Pharmacother; 2022 Apr; 23(6):681-691. PubMed ID: 35311434
[TBL] [Abstract][Full Text] [Related]
12. [Pericarditis].
Marques C; Cacoub P
Rev Prat; 2021 Jan; 71(1):79-83. PubMed ID: 34160952
[TBL] [Abstract][Full Text] [Related]
13. Recurrent pericarditis: new and emerging therapeutic options.
Imazio M; Lazaros G; Brucato A; Gaita F
Nat Rev Cardiol; 2016 Feb; 13(2):99-105. PubMed ID: 26259934
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 Antagonists for the Treatment of Recurrent Pericarditis.
Abadie BQ; Cremer PC
BioDrugs; 2022 Jul; 36(4):459-472. PubMed ID: 35639340
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease?
Picco P; Brisca G; Traverso F; Loy A; Gattorno M; Martini A
Arthritis Rheum; 2009 Jan; 60(1):264-8. PubMed ID: 19116906
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune and Autoinflammatory Pericarditis: Definitions and New Treatments.
Bizzi E; Trotta L; Pancrazi M; Nivuori M; Giosia V; Matteucci L; Montori D; Brucato A
Curr Cardiol Rep; 2021 Jul; 23(9):128. PubMed ID: 34319478
[TBL] [Abstract][Full Text] [Related]
17. New Insights into Pericarditis: Mechanisms of Injury and Therapeutic Targets.
Xu B; Harb SC; Cremer PC
Curr Cardiol Rep; 2017 Jul; 19(7):60. PubMed ID: 28528454
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and Safety of Anakinra for Management of Refractory Pericarditis.
Jain S; Thongprayoon C; Espinosa RE; Hayes SN; Klarich KW; Cooper LT; Moder KG; Anavekar NS; Oh JK; Matteson EL
Am J Cardiol; 2015 Oct; 116(8):1277-9. PubMed ID: 26279106
[TBL] [Abstract][Full Text] [Related]
19. Use of Interleukin-1 Blockers in Pericardial and Cardiovascular Diseases.
Emmi G; Urban ML; Imazio M; Gattorno M; Maestroni S; Lopalco G; Cantarini L; Prisco D; Brucato A
Curr Cardiol Rep; 2018 Jun; 20(8):61. PubMed ID: 29904899
[TBL] [Abstract][Full Text] [Related]
20. Idiopathic Pericarditis-an Autoinflammatory Disease?
Blank N; Lorenz HM
Curr Rheumatol Rep; 2019 Mar; 21(5):18. PubMed ID: 30852700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
